Overexpression of Erb-B2 receptor tyrosine kinase 4 (ERBB4) can rejuvenate aged MSCs and stimulate angiogenesis by regulating the PI3K/AKT and the MAPK/ERK pathways, leading to increased therapeutic effects for myocardial infarction [190]. This evidence concerns the gene ERBB4 and myocardial infarction.